Welcome to BenchFly!

who we are and why we're cloning a guy named chad

bench•fly  \'ben-ch,fl-eye'\ 

We're not a drosophila lab. Nor do we make benches for upper-body workouts, so if you're holding a testtube full of flies or wearing Zubaz, you might be on the wrong page.
In 2009, BenchFly was launched by a third-generation scientist determined to change the way scientists are educated, trained, and ultimately empowered to enable their next big breakthroughs. We have evolved into a full-service video production, hosting, and distribution platform servicing research labs and companies.

Two words: Science. Video.

Here's what you need to know about our founder:
1. He comes from a family of scientists. His father and grandfather are both chemists.
2. He believes video is the most powerful way to train scientists.
3. He's a connoisseur of stand-up comedy.
Why is this important? Because science and the desire to reach people, to communicate some deeper truth in a compelling and often funny way, are ingrained in Alan. They're almost literally part of his DNA. And they're at the very core of what BenchFly is about. 
We believe in video just like we believe in the scientists who are using it to advance human health.

Everybody should have a Chad

We felt so strongly that we cloned him. Here's why you should, too.

Science is hard enough. Video shouldn't make it harder.

"BenchFly's passion for research and video is infectious. They handled all of the logistics while making the shoot fun and stress-free, which everyone really appreciated!"
Laura Miller, Program Manager, Micro and Nanotechnology Lab University of Illinois at Urbana-Champaign 
A Conversation with our founder
Alan Marnett, Ph.D.)
BF - BenchFly was born in 2009 out of your own experience as a researcher. What compelled you to take action?
Alan - I was incredibly fortunate both as an undergraduate and a graduate student to be trained by very talented - and patient - scientists. I realized that not everyone was so lucky and I saw many of my classmates struggle and ultimately lose interest in science due to lack of proper training. At some point I just couldn't watch it happen anymore so I thought it was time to do something about it.
BF - Do you have a "business philosophy" that you try to bring to BenchFly?
Alan - You know, it's easy to get caught up in the new trendy book or lingo, but we believe strongly in treating people how we would want to be treated. Pretty simple stuff. They call it the Golden Rule for a reason, I guess. If we can help you, we're all in. If we can't, we'll let you know and point you in the right direction. 
BF - So can we now call that official policy?  
Alan - I suppose. It's really just fairness. My wife jokes around with me that I'm a typical Virgo because I'm all about rules and fairness. I never understood why the positions of Jupiter and Neptune at the time I was born should affect me, but they clearly did. In any event, when we work with someone, we want it to be fair. If we can't uphold our end of the bargain, that's wouldn't be fair. So we go to great pains to make sure that doesn't happen.
BF - So what helped get you over the hump to get BenchFly off the ground?  
Alan - Two things. First, internet bandwidth and technology evolved to a point where I could see how this resource could become viable. If it was 1996, watching a 60-second protocol video would have taken a week and a half...probably not terribly useful if you need to do an experiment that afternoon. Second, the community at MIT was very entrepreneurial, so I found a tremendous amount of support there. They say timing is everything and I was very fortunate that these things fell in place as they did.
BF - What excites you most about the future of video in science?
Alan - We haven't even scratched the surface yet. I think people will be blown away at where we - science - are with video in five years.
BF - You've recently instated a 26 week vacation policy, why is that?
Alan - Hahaha! Nice try. 
BF - I had to give it a shot. 


Matthew Bogyo, Ph.D.
Matt is an Associate Professor in the Departments of Pathology and Microbiology and Immunology at Stanford. He received his Ph.D. in Chemistry from MIT and was appointed as a Faculty Fellow in the Department of Biochemistry and Biophysics at the University of California, San Francisco. Prior to his current position, Matt served as the Head of Chemical Proteomics at Celera Genomics from 2001 to 2003. His research interests are focused on the use of chemistry to study the role of proteases in human disease.
Michael Marletta, Ph.D.
Michael is the President and CEO of The Scripps Research Institute. He serves on the Board of Editors of ACS Chemical Biology and on the editorial board of Proceedings of the National Academy of Sciences. Michael is a member of the Institute of Medicine and the National Academy of Sciences and is also a co-founder of Omniox, Inc.
Peter Pezaris
Peter is the Founder and CEO of Glip, Inc. Prior to Glip, he was the President and Founder of Multiply.com, a social networking site with >20M users. Peter also founded online fantasy sports company, Daedalus Worldwide Corporation, later sold to CBS where he served as CBS SportsLine.com's President of Operations and Product Development.
Alan Saghatelian, Ph.D.
Alan is an assistant professor in the Department of Chemistry and Chemical Biology at Harvard University. He received an NIH Director’s New Innovator Award and was named a Searle Scholar in 2008. Alan’s research focuses on the development and application of liquid chromatography-mass spectrometry-based global metabolite profiling as a general discovery tool in chemical biology.
Leona Samson, Ph.D.
Leona is an American Cancer Society Research Professor of Toxicology and Biological Engineering at MIT. She is also the Director of MIT’s Center for Environmental Health Sciences and a member of the Institute of Medicine. Her research focuses on how cells, tissues, and animals respond to environmental toxicants.
Waneta Tuttle, Ph.D., M.B.A.
Waneta is the Owner and CEO of Southwest Medical Ventures. A serial entrepreneur, she is the Founding CEO of PhDX, Indigo Medical, LifeSpex and i-Medik. Waneta serves as the Director of Health Care Service Corporation, a mutual legal reserve company operating Blue Cross/Blue Shield of Illinois, New Mexico, Oklahoma and Texas.

So, how can we help you? 

Want us to help you use video to impact your company or lab? Get in touch with us to see if there's a good fit. We're ready when you are.